Cymbalta(duloxetine)
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Cymbalta(duloxetine) as PDF for free.
More details
- Words: 306
- Pages: 1
NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name Trade Name Duloxetine Cymbalta Peak 6 hours
Classification Selective serotonin and norepinephrine reuptake inhibitors
Onset Unknown
Dose 90 mg
Duration 12 hours
Route PO
Time/frequency QHS
Normal dosage range 20-30 mg per day for depression or 60 mg per day for neuropathic pain
Why is your patient getting this medication Bipolar Disorder, DMII
For IV meds, compatibility with IV drips and/or solutions N/A
Mechanism of action and indications (Why med ordered) Inhibits serotonin and norepinephrine reuptake in the CNS. Indicated for Major depressive disorder, in conjunction with psychotherapy. Management of diabetic neuropathic pain
Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity and concurrent MAOI therapy. Uncontrolled narrow angle glaucoma, end stage renal failure, Chronic hepatic impairment or substantial alcohol use. Use cautiously if there is history of suicide attempt or mania as it may activate mania/hypomania, diabatic patients or those with renal failure.
Common side effects Fatigue, drowsiness, insomnia, decreased apetite, constipation, dry mouth, nausea, dysuria, increased sweating.
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) Risk of hepatotoxicity with chronic alcohol abuse
Lab value alterations caused by medicine May cause in increased ALT,AST, bilirubin, CPK, and alkaline phosphatase Be sure to teach the patient the following about this medication Take as directed at the same time each day, don’t stop abruptly. Be alert for anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, mania, worsening depression and suicidal ideation. May cause drowsiness. Notify provider of signs of liver damage. Avoid taking alcohol.
Nursing Process- Assessment (Pre-administration assessment) Monitor BP, appetite, Depression, pain
Assessment Why would you hold or not give this med? You wouldn’t, needs to be gradually decreased
Evaluation Check after giving Increased sense of well being and decreased neuropathic pain
Classification Selective serotonin and norepinephrine reuptake inhibitors
Onset Unknown
Dose 90 mg
Duration 12 hours
Route PO
Time/frequency QHS
Normal dosage range 20-30 mg per day for depression or 60 mg per day for neuropathic pain
Why is your patient getting this medication Bipolar Disorder, DMII
For IV meds, compatibility with IV drips and/or solutions N/A
Mechanism of action and indications (Why med ordered) Inhibits serotonin and norepinephrine reuptake in the CNS. Indicated for Major depressive disorder, in conjunction with psychotherapy. Management of diabetic neuropathic pain
Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity and concurrent MAOI therapy. Uncontrolled narrow angle glaucoma, end stage renal failure, Chronic hepatic impairment or substantial alcohol use. Use cautiously if there is history of suicide attempt or mania as it may activate mania/hypomania, diabatic patients or those with renal failure.
Common side effects Fatigue, drowsiness, insomnia, decreased apetite, constipation, dry mouth, nausea, dysuria, increased sweating.
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) Risk of hepatotoxicity with chronic alcohol abuse
Lab value alterations caused by medicine May cause in increased ALT,AST, bilirubin, CPK, and alkaline phosphatase Be sure to teach the patient the following about this medication Take as directed at the same time each day, don’t stop abruptly. Be alert for anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, mania, worsening depression and suicidal ideation. May cause drowsiness. Notify provider of signs of liver damage. Avoid taking alcohol.
Nursing Process- Assessment (Pre-administration assessment) Monitor BP, appetite, Depression, pain
Assessment Why would you hold or not give this med? You wouldn’t, needs to be gradually decreased
Evaluation Check after giving Increased sense of well being and decreased neuropathic pain
More Documents from "Cassie"
Prednisone
November 2019 36
Tylenol3
November 2019 35
New
November 2019 76
Miralax
November 2019 39
Furosemide
November 2019 35